IO Biotech (NASDAQ:IOBT) just reported results for the fourth quarter of 2023.
- IO Biotech reported earnings per share of -40 cents. This was below the analyst estimate for EPS of -39 cents.
- The company did not report any revenue for the quarter.
Source: iQoncept / Shutterstock
IO Biotech (NASDAQ:IOBT) just reported results for the fourth quarter of 2023.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/iobt-stock-earnings-io-biotech-for-q4-of-2023/.
©2025 InvestorPlace Media, LLC